Premier Genetics Inc. Announces Strategic Alliance Agreement with EnLyfe Nutraceutical Research Group Inc.



Premier Genetics, Inc., a subsidiary of Premier Holdings Group, Inc. (OTC: PHDG) announced today that the company has signed a strategic alliance agreement with En-Lyfe Nutraceutical Research Group, Inc. En-Lyfe specializes in natural medicines used to arrest Diabetes, HIV/AIDS, Cancer, Malaria, and Arthritis with no further degeneration of health.

En-Lyfe is headed by Dr. James Hall (Epidemiologist) who has devoted the last 15 years of his life to the research of Natural medicines and/or Nutraceuticals. Dr. Hall was commissioned under the Clinton administration to serve as Goodwill Ambassador to Sub-Sahara Africa. Dr. Hall counseled with Nelson Mandela and his national medical professionals to develop and affordable response to HIV/AIDS. En-Lyfe is armed with client testimonials and other documentation fully supporting the authenticity and positive results of clients who have used and benefited from alternative based products.

Premier Genetics, signed the strategic alliance agreement with En-Lyfe because the company believes that the market for Digestive Enzymes is literally untapped. Dr. Hall has a documented clinical study with En-Lyfe's8217;s 's8220;Out of Nature's8482;'s8221; product line. The product line is based on, and derived from the long-held International studies and theoretical practices of natural enzymes being the vital 's8220;life force's8221; of every body for enhancing and sustaining good health among all individuals's8230;men, women, youth, children and the sport industry.

The underlying premise for taking a digestive enzymes supplement is the capacity for better nutrient absorption through enhanced digestion. Despite significant medical advances and rapid FDA approval in recent years, the sobering unchanging rates and disparities of those suffering from epidemic degenerative and infectious diseases, consistently representing over 65 percent mortality ratesworldwideunderscores the fact that current new drug therapies to decrease and/or eliminate the effects of these diseases 's8230;remain limited in their effectiveness.

Premier Genetics, Inc. is a subsidiary of Premier Holdings Group, Inc. (OTC: PHDG). The company specializes in collection services for DNA/Paternity Testing, Immigration ID, Sibling Testing, & DNA Profiling.

Premier Genetics, Inc.
148C Valley Hill Rd
Riverdale, GA 30274
770-572-4229

En-Lyfe Nutraceutical Research Group, Inc
En-Lyfe Charities, Inc.
(A division of) En-Lyfe Health Foundation's8482;
P.O. Box 1723
Decatur, Georgia 30031
404-275-1403





Premier Genetics Inc. Announces Strategic Alliance Agreement with EnLyfe Nutraceutical Research Group Inc.